|
CAS No.
|
ABX
Product No.
|
Structure
|
Datasheet
HTML
|
Datasheet
PDF
|
Mannose Triflate, ultra pure
|
|
[92051-23-5]
|
100
|
|
100.html
|
100.pdf
|
Mannose Triflate, ultra pure
packing for GE TRACERlab MXFDG
|
|
[92051-23-5]
|
101
|
|
101.html
|
101.pdf
|
Mannose Triflate, ultra pure
packing for FDG MicroLab (GE)
|
|
[92051-23-5]
|
102
|
|
102.html
|
102.pdf
|
Mannose Triflate PLUS, ultra pure
|
|
[92051-23-5]
|
105
|
|
105.html
|
105.pdf
|
Mannose Triflate PLUS, ultra pure
|
|
[92051-23-5]
|
107
|
|
107.html
|
107.pdf
|
Cryptand 222
|
|
[23978-09-8]
|
800
|
|
800.html
|
800.pdf
|
Lithium aluminium hydride 1M
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere does not affect product quality.
|
|
[16853-85-3]
|
801
|
|
801.html
|
801.pdf
|
Lithium aluminium hydride 0.1 M
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere does not affect product quality.
|
|
|
802
|
|
802.html
|
802.pdf
|
Lithium aluminium hydride 0.25 M
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere does not affect product quality.
|
|
|
803
|
|
803.html
|
803.pdf
|
Lithium aluminium hydride 0.05 M
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere does not affect product quality.
|
|
|
804
|
|
804.html
|
804.pdf
|
TBA HCO3 0.075 M
|
|
[17351-62-1]
|
808
|
|
808.html
|
808.pdf
|
TBA HCO3 0.075 M
|
|
|
809
|
|
809.html
|
809.pdf
|
TBA HCO3 0.075 M
|
|
|
810
|
|
810.html
|
810.pdf
|
Hydriodic acid Redistilled
Manufactured and packaged in argon atmosphere. Storage at 5±3 degC
|
|
[10034-85-2]
|
830
|
|
830.html
|
830.pdf
|
Pentadecylmagnesium bromide 0.5 M solution in diethyl ether
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere possible, but not recommended.
|
|
[78887-70-4]
|
831
|
|
831.html
|
831.pdf
|
Lithium aluminium hydride 0.1 M
Manufactured and packaged in argon atmosphere. Repeated extractions from vial in argon atmosphere does not affect product quality.
|
|
|
832
|
|
832.html
|
832.pdf
|
FDG
|
[86783-82-6] (cyclic form) [29702-43-0] (aldehyde form)
|
1100
|
|
1100.html
|
1100.pdf
|
6-FDG Precursor
|
|
[899808-81-2]
|
1109
|
|
1109.html
|
1109.pdf
|
ClDG
|
|
[14685-79-1]
|
1110
|
|
1110.html
|
1110.pdf
|
MBBTG
|
|
[107794-71-8]
|
1119
|
|
1119.html
|
1119.pdf
|
FDM
|
|
[31077-88-0]
|
1120
|
|
1120.html
|
1120.pdf
|
ACY-FDG
|
|
[141395-48-4]
|
1130
|
|
1130.html
|
1130.pdf
|
1,2,3,4-tetra-O-acetyl-beta-D-glucopyranose
|
|
[13100-46-4]
|
1131
|
|
1131.html
|
1131.pdf
|
Talose Triflate
|
|
CAS-RN not yet assigned
|
1140
|
|
1140.html
|
1140.pdf
|
FDGal
|
|
[7226-39-3]
|
1150
|
|
1150.html
|
1150.pdf
|
DMTr-lyxothymidine
|
|
[112501-53-8]
|
1180
|
|
1180.html
|
1180.pdf
|
DMTr-Nosyl-lyxothymidine
|
|
[444717-20-8]
|
1190
|
|
1190.html
|
1190.pdf
|
Dimethoxybenzyl-FLT-precursor
|
|
[290371-75-4]
|
1200
|
|
1200.html
|
1200.pdf
|
Anhydrothymidine-FLT-precursor
|
|
[191474-13-2]
|
1210
|
|
1210.html
|
1210.pdf
|
3′-Fluoro-thymidine (FLT)
|
|
[25526-93-6]
|
1220
|
|
1220.html
|
1220.pdf
|
3′-Iodo-thymidine
|
|
[14260-82-3]
|
1222
|
|
1222.html
|
1222.pdf
|
5′-O-Benzoyl-2,3′-anhydrothymidine
|
|
[70838-44-7]
|
1230
|
|
1230.html
|
1230.pdf
|
5′-O-Benzoyl-2,3′-anhydrothymidine (GMP)
|
|
[70838-44-7]
|
1231
|
|
1231.html
|
1231.pdf
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine
|
|
[444717-23-1]
|
1240
|
|
1240.html
|
1240.pdf
|
3-N-Boc-5′-O-dimethoxytrityl-3′-O-nosyl-thymidine (GMP)
|
|
[444717-23-1]
|
1241
|
|
1241.html
|
1241.pdf
|
2,2′-Anhydrothymidine
|
|
[22423-26-3]
|
1250
|
|
1250.html
|
1250.pdf
|
2′-Fluoro-thymidine
|
|
[122799-38-6]
|
1260
|
|
1260.html
|
1260.pdf
|
3-N-Boc-5′-O-dimethoxytrityl-3′-fluorothymidine
|
|
[138685-99-1]
|
1261
|
|
1261.html
|
1261.pdf
|
DEMM
|
|
[93504-92-8]
|
1280
|
|
1280.html
|
1280.pdf
|
Thymidine
|
|
[50-89-5]
|
1290
|
|
1290.html
|
1290.pdf
|
6-Trimethylstannyl-L-DOPA
Sold under license for US patent No. 5,393,908
|
|
[143993-90-2]
|
1300
|
|
1300.html
|
1300.pdf
|
6-Trimethylstannyl-D,L-DOPA
|
|
CAS-RN not yet assigned
|
1302
|
|
1302.html
|
1302.pdf
|
6-Trimethylstannyl-D-DOPA
|
|
CAS-RN not yet assigned
|
1303
|
|
1303.html
|
1303.pdf
|
6-Fluoro-L-DOPA Hydrochloride
|
|
[144334-59-8]
|
1310
|
|
1310.html
|
1310.pdf
|
6-Fluoro-D,L-DOPA Hydrochloride
|
|
CAS-RN not yet assigned
|
1311
|
|
1311.html
|
1311.pdf
|
DiBoc-Iodo-L-DOPA
|
|
[143993-89-9]
|
1320
|
|
1320.html
|
1320.pdf
|
4-O-Pivaloyl-L-DOPA
|
|
[122551-95-5]
|
1330
|
|
1330.html
|
1330.pdf
|
6-Hydroxy-D,L-DOPA
|
|
[21373-30-8]
|
1332
|
|
1332.html
|
1332.pdf
|
TriBoc-L-DOPA methyl ester
|
|
[857502-21-7]
|
1340
|
|
1340.html
|
1340.pdf
|
TriBoc-L-DOPA ethyl ester
|
|
[203398-46-3]
|
1342
|
|
1342.html
|
1342.pdf
|
TriBoc-Iodo-L-DOPA
|
|
[853759-55-4]
|
1350
|
|
1350.html
|
1350.pdf
|
OMFD-Precursor ABX 004
|
|
CAS-RN not yet assigned
|
1363
|
|
1363.html
|
1363.pdf
|
OMFD
Metabolite of 6-Fluoro-L-DOPA
|
|
[114077-01-9]
|
1369
|
|
1369.html
|
1369.pdf
|
N-Trifluoroacetyl-3,4-dimethoxy-6-trimethylstannyl-phenethylamine
|
|
[170465-14-2]
|
1370
|
|
1370.html
|
1370.pdf
|
N-Trifluoroacetyl-3,4-di-tert-butoxycarbonyloxy-6-trimethylstannyl-phenethylamine
|
|
[170953-68-1]
|
1371
|
|
1371.html
|
1371.pdf
|
6-Fluorodopamine
|
|
[71144-39-3]
|
1380
|
|
1380.html
|
1380.pdf
|
NITTP
|
|
[150196-34-2]
|
1400
|
|
1400.html
|
1400.pdf
|
NITTP (GMP)
|
|
[150196-34-2]
|
1401
|
|
1401.html
|
1401.pdf
|
NITTP (GMP)
|
|
[150196-34-2]
|
1402
|
|
1402.html
|
1402.pdf
|
Fluoromisonidazole
|
|
[13551-89-8]
|
1410
|
|
1410.html
|
1410.pdf
|
Desmethylmisonidazole
|
|
[13551-92-3]
|
1420
|
|
1420.html
|
1420.pdf
|
FETNIM Precursor
|
|
[163714-99-6]
|
1430
|
|
1430.html
|
1430.pdf
|
FETNIM
|
|
CAS-RN not yet assigned
|
1440
|
|
1440.html
|
1440.pdf
|
1-(2,3-Diacetyl-5-tosyl-(alpha-D-arabinofuranosyl)-2-nitroimidazole
|
|
[494775-35-8]
|
1450
|
|
1450.html
|
1450.pdf
|
1-(5-Deoxy-5-fluoro-alpha-D-arabinofuranosyl)-2-nitroimidazole
|
|
[220793-03-3]
|
1451
|
|
1451.html
|
1451.pdf
|
N-(2-Tosyloxyethyl)phthalimide
|
|
[5460-83-3]
|
1452
|
|
1452.html
|
1452.pdf
|
2,3,5,6-Tetrafluorophenyl-2-(2-nitroimidazol-1-yl)acetate
|
|
[199734-70-8]
|
1453
|
|
1453.html
|
1453.pdf
|
N-(2-Fluoroethyl)-2-(2-nitroimidazol-1-yl)acetamide
|
|
[199800-19-6]
|
1454
|
|
1454.html
|
1454.pdf
|
ATSM
|
|
[63618-91-7]
|
1455
|
|
1455.html
|
1455.pdf
|
PTSM
|
|
[673-68-7]
|
1456
|
|
1456.html
|
1456.pdf
|
CuATSM
|
|
[68341-09-3]
|
1457
|
|
1457.html
|
1457.pdf
|
ATSM (GMP)
|
|
[63618-91-7]
|
1458
|
|
1458.html
|
1458.pdf
|
NiATSM
|
|
[30193-04-5]
|
1459
|
|
1459.html
|
1459.pdf
|
(R)-SCH-24518 hydrochloride
|
|
[128145-75-5]
|
1460
|
|
1460.html
|
1460.pdf
|
(S)-SCH-24518 hydrochloride
|
|
[1217462-17-3]
|
1462
|
|
1462.html
|
1462.pdf
|
SCH-23390 hydrochloride
|
|
[125941-87-9]
|
1464
|
|
1464.html
|
1464.pdf
|
SCH-23388 hydrochloride
|
|
[1217443-99-6]
|
1466
|
|
1466.html
|
1466.pdf
|
(R)-(-)-Norapomorphine hydrobromide
Photosensitive
|
|
[115017-61-3]
|
1477
|
|
1477.html
|
1477.pdf
|
(+)-Desmethyl-NNC112
|
|
[221132-62-3]
|
1480
|
|
1480.html
|
1480.pdf
|
(+)-NNC112
|
|
[125341-24-4]
|
1490
|
|
1490.html
|
1490.pdf
|
(S)-O-Desmethylraclopride hydrobromide
|
|
[113310-88-6]
|
1500
|
|
1500.html
|
1500.pdf
|
(R)-O-Desmethylraclopride hydrobromide
|
|
[113310-87-5]
|
1501
|
|
1501.html
|
1501.pdf
|
(R,S)-O-Desmethylraclopride hydrobromide
|
|
CAS-RN not yet assigned
|
1502
|
|
1502.html
|
1502.pdf
|
(S)-O-Desmethylraclopride
|
|
[119670-11-0]
|
1510
|
|
1510.html
|
1510.pdf
|
Raclopride
|
|
[84225-95-6]
|
1520
|
|
1520.html
|
1520.pdf
|
FLB 604
|
|
[128600-22-6]
|
1530
|
|
1530.html
|
1530.pdf
|
FLB 457
|
|
[107188-74-9]
|
1540
|
|
1540.html
|
1540.pdf
|
Tosyl-Fallypride
|
|
[166173-74-6]
|
1550
|
|
1550.html
|
1550.pdf
|
Fallypride
|
|
[166173-78-0]
|
1560
|
|
1560.html
|
1560.pdf
|
Fallypride tartrate salt
|
|
CAS-RN not yet assigned
|
1561
|
|
1561.html
|
1561.pdf
|
Tosyl-Desmethoxyfallypride
|
|
[713135-14-9]
|
1570
|
|
1570.html
|
1570.pdf
|
Desmethoxyfallypride
|
|
[166173-81-5]
|
1580
|
|
1580.html
|
1580.pdf
|
N-Mesitylenesulfonyloxy-ethyl-spiperone
|
|
[128584-73-6]
|
1590
|
|
1590.html
|
1590.pdf
|
Fluoroethyl-spiperone
|
|
[106114-42-5]
|
1591
|
|
1591.html
|
1591.pdf
|
D-threo-N-NPS-Ritalinic acid
|
|
[159701-28-7]
|
1592
|
|
1592.html
|
1592.pdf
|
D-threo-Methylphenidate Hydrochloride
Controlled substance, license required in most countries.
|
|
[19262-68-1]
|
1593
|
|
1593.html
|
1593.pdf
|
(R)-N-Desmethyl PK11195
|
|
[157809-85-3]
|
1600
|
|
1600.html
|
1600.pdf
|
(R)-PK11195
|
|
[85340-56-3]
|
1610
|
|
1610.html
|
1610.pdf
|
(R,S)-PK11195
|
|
[85532-75-8]
|
1611
|
|
1611.html
|
1611.pdf
|
(S)-N-Desmethyl PK11195
|
|
[157809-86-4]
|
1620
|
|
1620.html
|
1620.pdf
|
(R,S)-N-Desmethyl PK11195
|
|
[124236-61-9]
|
1640
|
|
1640.html
|
1640.pdf
|
(+)-9-MeO-HNO hydrochloride
|
|
[99833-85-9]
|
1642
|
|
1642.html
|
1642.pdf
|
(+)-HNO hydrochloride
|
|
[858517-21-2]
|
1643
|
|
1643.html
|
1643.pdf
|
(+)-PHNO hydrochloride
|
|
[99705-65-4]
|
1645
|
|
1645.html
|
1645.pdf
|
(+)-F-PHNO
|
|
[905963-70-4]
|
1646
|
|
1646.html
|
1646.pdf
|
PBR28 Precursor
|
|
[1005325-42-7]
|
1652
|
|
1652.html
|
1652.pdf
|
PBR28 Standard
|
|
[253307-72-1]
|
1653
|
|
1653.html
|
1653.pdf
|
Azidomazenil
|
|
[91917-65-6]
|
1680
|
|
1680.html
|
1680.pdf
|
Nitromazenil
|
|
[84377-97-9]
|
1690
|
|
1690.html
|
1690.pdf
|
Desmethylflumazenil
|
|
[79089-72-8]
|
1700
|
|
1700.html
|
1700.pdf
|
Flumazenil
|
|
[78755-81-4]
|
1710
|
|
1710.html
|
1710.pdf
|
Flumazenil acid
|
|
[84378-44-9]
|
1720
|
|
1720.html
|
1720.pdf
|
TFMZ (Tosyloxyethylflumazenil)
|
|
[676437-17-5]
|
1721
|
|
1721.html
|
1721.pdf
|
Fluoroethylflumazenil
|
|
CAS-RN not yet assigned
|
1730
|
|
1730.html
|
1730.pdf
|
(R)-Metomidate Hydrochloride
|
|
[66392-64-2]
|
1760
|
|
1760.html
|
1760.pdf
|
(S)-Metomidate Hydrochloride
|
|
[66392-65-2]
|
1762
|
|
1762.html
|
1762.pdf
|
(R)-Etomidate
|
|
[33125-97-2]
|
1770
|
|
1770.html
|
1770.pdf
|
(R)-Desethyl-Etomidate
|
|
[56649-48-0]
|
1780
|
|
1780.html
|
1780.pdf
|
(S)-Desethyl-Etomidate
|
|
[56649-49-1]
|
1782
|
|
1782.html
|
1782.pdf
|
(R)-Fluoroethyl-Etomidate
|
|
[960403-07-0]
|
1790
|
|
1790.html
|
1790.pdf
|
Nitro-Altanserin
|
|
[139418-53-4]
|
1800
|
|
1800.html
|
1800.pdf
|
Altanserin
|
|
[76330-71-7]
|
1810
|
|
1810.html
|
1810.pdf
|
Nitro-Setoperone
|
|
[113981-16-1]
|
1820
|
|
1820.html
|
1820.pdf
|
Setoperone
|
|
[86487-64-1]
|
1830
|
|
1830.html
|
1830.pdf
|
MDL105725
|
|
[189192-18-5]
|
1840
|
|
1840.html
|
1840.pdf
|
MDL100907
|
|
[139290-65-6]
|
1850
|
|
1850.html
|
1850.pdf
|
MDL100151
|
|
[139290-69-0]
|
1860
|
|
1860.html
|
1860.pdf
|
MDL100907 tartrate salt
|
|
CAS-RN not yet assigned
|
1870
|
|
1870.html
|
1870.pdf
|
MMSE
|
|
[177714-21-5]
|
1900
|
|
1900.html
|
1900.pdf
|
16alpha-Fluoroestradiol
|
|
[92817-10-2]
|
1910
|
|
1910.html
|
1910.pdf
|
3-O-Trityl-6-O-desmethyl-diprenorphine
|
|
[157891-92-4]
|
2000
|
|
2000.html
|
2000.pdf
|
3-O-Trityl-6-O-desmethyl-diprenorphine (GMP)
|
|
[157891-92-4]
|
2001
|
|
2001.html
|
2001.pdf
|
Diprenorphine hydrochloride
Controlled substance, license required in most countries.
|
|
[16808-86-9]
|
2010
|
|
2010.html
|
2010.pdf
|
Diprenorphine
Controlled substance, license required in most countries.
|
|
[14357-78-9]
|
2020
|
|
2020.html
|
2020.pdf
|
3-O-Trityl-diprenorphine
|
|
[157891-91-3]
|
2030
|
|
2030.html
|
2030.pdf
|
6-O-Fluoroethyl-6-O-desmethyl-diprenorphine
|
|
CAS-RN not yet assigned
|
2040
|
|
2040.html
|
2040.pdf
|
6-O-Fluoroethyl-6-O-desmethyl-3-O-trityl-diprenorphine
|
|
CAS-RN not yet assigned
|
2050
|
|
2050.html
|
2050.pdf
|
3-O-Trityl-6-O-desmethyl-buprenorphine
|
|
[157891-93-5]
|
2055
|
|
2055.html
|
2055.pdf
|
Buprenorphin Hydrochloride
Controlled substance, license required in most countries.
|
|
[53152-21-9]
|
2056
|
|
2056.html
|
2056.pdf
|
(R)-(-)-Normethylcarbamoyl-GR103545
|
|
[199470-02-5]
|
2060
|
|
2060.html
|
2060.pdf
|
(S)-(+)-Normethylcarbamoyl-GR103545
|
|
[260992-21-0]
|
2061
|
|
2061.html
|
2061.pdf
|
Normethylcarbamoyl-GR89696
|
|
[126766-48-1]
|
2062
|
|
2062.html
|
2062.pdf
|
Acetic acid piperidin-4-yl ester hydrochloride
|
|
[94886-04-1]
|
2110
|
|
2110.html
|
2110.pdf
|
Acetic acid 1-methyl-piperidin-4-yl ester hydrochloride
|
|
[58931-63-8]
|
2120
|
|
2120.html
|
2120.pdf
|
Propionic acid piperidin-4-yl ester hydrochloride
|
|
[219859-83-3]
|
2130
|
|
2130.html
|
2130.pdf
|
Propionic acid 1-methyl-piperidin-4-yl ester hydrochloride
|
|
[64219-77-8]
|
2140
|
|
2140.html
|
2140.pdf
|
Butyric acid piperidin-4-yl ester hydrochloride
|
|
CAS-RN not yet assigned
|
2150
|
|
2150.html
|
2150.pdf
|
Butyric acid 1-methyl-piperidin-4-yl ester hydrochloride
|
|
CAS-RN not yet assigned
|
2160
|
|
2160.html
|
2160.pdf
|
L-Homocysteine
|
|
[6027-13-0]
|
2200
|
|
2200.html
|
2200.pdf
|
L-Homocysteine thiolactone hydrochloride
|
|
[31828-68-9]
|
2210
|
|
2210.html
|
2210.pdf
|
L-Methionine
|
|
[63-68-3]
|
2220
|
|
2220.html
|
2220.pdf
|
D-Methionine
|
|
[348-67-4]
|
2229
|
|
2229.html
|
2229.pdf
|
D,L-Methionine
|
|
[59-51-8]
|
2230
|
|
2230.html
|
2230.pdf
|
N-Boc-trans-4-tosyloxy-L-proline methyl ester
|
|
[88043-21-4]
|
2300
|
|
2300.html
|
2300.pdf
|
N-Boc-cis-4-tosyloxy-L-proline methyl ester
|
|
CAS-RN not yet assigned
|
2310
|
|
2310.html
|
2310.pdf
|
cis-4-Fluoro-L-proline
|
|
[2438-57-5]
|
2320
|
|
2320.html
|
2320.pdf
|
trans-4-Fluoro-L-proline
|
|
[2507-61-1]
|
2330
|
|
2330.html
|
2330.pdf
|
Desmethylcarfentanil acid
|
|
[186022-53-7]
|
2390
|
|
2390.html
|
2390.pdf
|
Desmethylcarfentanil, sodium salt
|
|
[98598-82-4]
|
2400
|
|
2400.html
|
2400.pdf
|
Desmethylcarfentanil, sodium salt (GMP)
|
|
[98598-82-4]
|
2401
|
|
2401.html
|
2401.pdf
|
Carfentanil oxalate
Controlled substance, license required in most countries.
|
|
[61086-44-0]
|
2410
|
|
2410.html
|
2410.pdf
|
Carfentanil oxalate (GMP)
Controlled substance, license required in most countries.
|
|
[61086-44-0]
|
2411
|
|
2411.html
|
2411.pdf
|
Fluoroethyl-Carfentanil
|
|
[904892-57-5]
|
2420
|
|
2420.html
|
2420.pdf
|
Fluoroethyl-Carfentanil Hydrochloride
|
|
[1007840-96-1]
|
2421
|
|
2421.html
|
2421.pdf
|
(R)-Desisopropylcarazolol
|
|
[143412-41-3]
|
2500
|
|
2500.html
|
2500.pdf
|
(S)-Desisopropylcarazolol
|
|
[143412-40-2]
|
2510
|
|
2510.html
|
2510.pdf
|
(R,S)-Desisopropylcarazolol
|
|
[72955-96-5]
|
2511
|
|
2511.html
|
2511.pdf
|
(R)-Carazolol
|
|
[78859-34-4]
|
2520
|
|
2520.html
|
2520.pdf
|
(S)-Carazolol
|
|
[78859-33-3]
|
2530
|
|
2530.html
|
2530.pdf
|
(R,S)-Carazolol
|
|
[57775-29-8]
|
2540
|
|
2540.html
|
2540.pdf
|
(S)-N-Desisopropylpropranolol
|
|
[88547-38-0]
|
2550
|
|
2550.html
|
2550.pdf
|
GB 99
|
|
[116784-78-2]
|
2570
|
|
2570.html
|
2570.pdf
|
GB 67
|
|
[116784-70-4]
|
2580
|
|
2580.html
|
2580.pdf
|
(S)-1-(2-Amino-3-nitrophenoxy)-3-tert-butylamino-propan-2-ol
|
|
[132059-12-2]
|
2590
|
|
2590.html
|
2590.pdf
|
4-(2-Keto-3-methyl-1-benzimidazolinyl)piperidine
|
|
[53786-10-0]
|
2700
|
|
2700.html
|
2700.pdf
|
Cyclopropyl-p-nitrophenyl ketone
|
|
[93639-12-4]
|
2750
|
|
2750.html
|
2750.pdf
|
FNMB
|
|
[133066-70-3]
|
2760
|
|
2760.html
|
2760.pdf
|
3-O-Benzyl-naltrindole
|
|
[161532-22-5]
|
2800
|
|
2800.html
|
2800.pdf
|
QNB
|
|
[6581-06-2]
|
2830
|
|
2830.html
|
2830.pdf
|
Me-QNB
|
|
[71861-83-1]
|
2840
|
|
2840.html
|
2840.pdf
|
Benzyl-14-(R,S)-tosyloxy-6-thiaheptadecanoate
|
|
[137564-70-6]
|
2850
|
|
2850.html
|
2850.pdf
|
14-(R,S)-Fluoro-6-thiaheptadecanoic acid
|
|
[137564-72-8]
|
2860
|
|
2860.html
|
2860.pdf
|
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-alpha-D-ribofuranose
|
|
[97614-41-0]
|
2870
|
|
2870.html
|
2870.pdf
|
5-Ethyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine
|
|
[31167-05-2]
|
2871
|
|
2871.html
|
2871.pdf
|
5-Methyl-2,4-bis[(trimethylsilyl)oxy]pyrimidine
|
|
[7288-28-0]
|
2872
|
|
2872.html
|
2872.pdf
|
FEAU
|
|
[83546-42-3]
|
2876
|
|
2876.html
|
2876.pdf
|
alphaFEAU
|
|
CAS-RN not yet assigned
|
2877
|
|
2877.html
|
2877.pdf
|
FMAU
|
|
[69256-17-3]
|
2878
|
|
2878.html
|
2878.pdf
|
alphaFMAU
|
|
[97672-34-9]
|
2879
|
|
2879.html
|
2879.pdf
|
FTRU
|
|
[336881-26-6]
|
2880
|
|
2880.html
|
2880.pdf
|
FTAU
|
|
[213136-14-2]
|
2890
|
|
2890.html
|
2890.pdf
|
FAU
|
|
[69123-94-0]
|
2900
|
|
2900.html
|
2900.pdf
|
FIAU
|
|
[69123-98-4]
|
2910
|
|
2910.html
|
2910.pdf
|
FUdR
|
|
[784-71-4]
|
2920
|
|
2920.html
|
2920.pdf
|
Di-THP-nosyl-AUR
|
|
[1000816-92-1]
|
2921
|
|
2921.html
|
2921.pdf
|
FIRU
|
|
[183293-80-3]
|
2922
|
|
2922.html
|
2922.pdf
|
3′-Fluoro-2′,3′-dideoxyuridine
|
|
[41107-56-6]
|
2940
|
|
2940.html
|
2940.pdf
|
5-Trimethylstannyl-2′-deoxyuridine
|
|
[146629-34-7]
|
2948
|
|
2948.html
|
2948.pdf
|
IUdR
|
|
[54-42-2]
|
2949
|
|
2949.html
|
2949.pdf
|
2′-Deoxy-L-uridine
|
|
[31501-19-6]
|
2950
|
|
2950.html
|
2950.pdf
|
Nitro-Xeloda
|
|
[865474-03-9]
|
2952
|
|
2952.html
|
2952.pdf
|
Xeloda
|
|
[154361-50-9]
|
2953
|
|
2953.html
|
2953.pdf
|
2′,3′-Didehydro-3′-deoxythymidine
|
|
[3056-17-5]
|
2954
|
|
2954.html
|
2954.pdf
|
Tosyl-FHBG
|
|
[206067-84-7]
|
2960
|
|
2960.html
|
2960.pdf
|
FHBG
|
|
[206067-83-6]
|
2970
|
|
2970.html
|
2970.pdf
|
N,O-Di-Boc-2-TMSn-L-tyrosine ethyl ester
|
|
[400885-40-7]
|
3000
|
|
3000.html
|
3000.pdf
|
2-Fluoro-tyrosine
|
|
[78709-81-6]
|
3010
|
|
3010.html
|
3010.pdf
|
2-Iodo-tyrosine
|
|
[78853-38-0]
|
3020
|
|
3020.html
|
3020.pdf
|
TET
|
|
[478037-15-9]
|
3050
|
|
3050.html
|
3050.pdf
|
FET
|
|
CAS-RN not yet assigned
|
3060
|
|
3060.html
|
3060.pdf
|
D-FET
|
|
CAS-RN not yet assigned
|
3070
|
|
3070.html
|
3070.pdf
|
HET trifluoroacetate
|
|
CAS-RN not yet assigned
|
3080
|
|
3080.html
|
3080.pdf
|
N-Trifluoroacetyl-5-acetoxy-2-trimethylstannyl-phenylalanine ethyl ester
|
|
[148613-10-9]
|
3100
|
|
3100.html
|
3100.pdf
|
N-Boc-5-O-Boc-2-trimethylstannyl-phenylalanine ethyl ester
|
|
[845882-24-8]
|
3110
|
|
3110.html
|
3110.pdf
|
2-Fluoro-m-Tyrosine
|
|
[148613-12-1]
|
3130
|
|
3130.html
|
3130.pdf
|
2-Iodo-alpha-methyl-p-tyrosine
|
|
CAS-RN not yet assigned
|
3180
|
|
3180.html
|
3180.pdf
|
3-Iodo-alpha-methyl-p-tyrosine
|
|
[4298-17-3]
|
3190
|
|
3190.html
|
3190.pdf
|
Nitro-MPPF
|
|
[155204-27-6]
|
3240
|
|
3240.html
|
3240.pdf
|
MPPF
|
|
[155204-26-5]
|
3250
|
|
3250.html
|
3250.pdf
|
Desmethyl-MPT
|
|
[874471-23-5]
|
3260
|
|
3260.html
|
3260.pdf
|
MPT
|
|
[179756-59-3]
|
3270
|
|
3270.html
|
3270.pdf
|
TAP
|
|
[213766-21-3]
|
3300
|
|
3300.html
|
3300.pdf
|
IAP
|
|
[213764-92-2]
|
3310
|
|
3310.html
|
3310.pdf
|
Nitro-AP
|
|
[209530-92-7]
|
3320
|
|
3320.html
|
3320.pdf
|
FAP tartrate
|
|
CAS-RN not yet assigned
|
3340
|
|
3340.html
|
3340.pdf
|
TMA-AP
|
|
[233766-75-1]
|
3350
|
|
3350.html
|
3350.pdf
|
Nitro-Nifene
|
|
[912843-70-0]
|
3360
|
|
3360.html
|
3360.pdf
|
Nifene
|
|
CAS-RN not yet assigned
|
3370
|
|
3370.html
|
3370.pdf
|
Metaraminol (free base)
|
|
[54-49-9]
|
3380
|
|
3380.html
|
3380.pdf
|
Metaraminol bitartrate
|
|
[33402-03-8]
|
3390
|
|
3390.html
|
3390.pdf
|
MHED hydrochloride
|
|
[24493-89-8]
|
3400
|
|
3400.html
|
3400.pdf
|
Desmethyl-GR 205171
|
|
[180574-25-8]
|
3500
|
|
3500.html
|
3500.pdf
|
GR 205171
|
|
[168266-90-8]
|
3510
|
|
3510.html
|
3510.pdf
|
Desmethyl-GR 205171 Dihydrochloride
|
|
[262598-97-0]
|
3520
|
|
3520.html
|
3520.pdf
|
GR 205171 Dihydrochloride
|
|
[168266-51-1]
|
3530
|
|
3530.html
|
3530.pdf
|
Desmethyl-CNS 5161
|
|
[160754-78-9]
|
3540
|
|
3540.html
|
3540.pdf
|
CNS 5161
|
|
[160754-76-7]
|
3550
|
|
3550.html
|
3550.pdf
|
Desmethyl-SCH 442416
|
|
[188112-92-7]
|
3700
|
|
3700.html
|
3700.pdf
|
SCH 442416
|
|
[316173-57-6]
|
3710
|
|
3710.html
|
3710.pdf
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane
|
|
[50370-56-4]
|
4000
|
|
4000.html
|
4000.pdf
|
(-)-2-beta-Carbomethoxy-3-beta-(4-fluorophenyl)nortropane
|
|
[127648-30-0]
|
4020
|
|
4020.html
|
4020.pdf
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)tropane
|
|
[135416-43-2]
|
4030
|
|
4030.html
|
4030.pdf
|
TMS-CT
|
|
[158111-10-5]
|
4040
|
|
4040.html
|
4040.pdf
|
TBS-CT
|
|
[136794-88-2]
|
4041
|
|
4041.html
|
4041.pdf
|
(-)-2-beta-Carbomethoxy-3-beta-(4-iodophenyl)nortropane
|
|
[136794-87-1]
|
4050
|
|
4050.html
|
4050.pdf
|
(-)-2-beta-Carbomethoxy-3-beta-(phenyl)tropane
|
|
[50372-80-0]
|
4060
|
|
4060.html
|
4060.pdf
|
CITFES
|
|
[180045-77-6]
|
4100
|
|
4100.html
|
4100.pdf
|
CITFE
|
|
[155798-01-9]
|
4110
|
|
4110.html
|
4110.pdf
|
CITTP Tosylat
|
|
CAS-RN not yet assigned
|
4122
|
|
4122.html
|
4122.pdf
|
CITFP
|
|
[155797-99-2]
|
4130
|
|
4130.html
|
4130.pdf
|
TBSCT-FP
|
|
[479642-48-3]
|
4132
|
|
4132.html
|
4132.pdf
|
beta-CIT acid
|
|
[141807-58-1]
|
4140
|
|
4140.html
|
4140.pdf
|
2-FE-beta-CIT
|
|
[398497-81-9]
|
4150
|
|
4150.html
|
4150.pdf
|
PE2I acid
|
|
[311351-26-5]
|
4160
|
|
4160.html
|
4160.pdf
|
PE2I acid (GMP)
|
|
[311351-26-5]
|
4161
|
|
4161.html
|
4161.pdf
|
PE2I
|
|
[188680-71-9]
|
4170
|
|
4170.html
|
4170.pdf
|
PE2I (GMP)
|
|
[188680-71-9]
|
4171
|
|
4171.html
|
4171.pdf
|
Nor-beta-CClT
|
|
[146725-33-9]
|
4180
|
|
4180.html
|
4180.pdf
|
FECNT
|
|
[281667-94-5]
|
4190
|
|
4190.html
|
4190.pdf
|
Altropane acid
|
|
[335104-67-1]
|
4200
|
|
4200.html
|
4200.pdf
|
Altropane acid hydrochloride
|
|
CAS-RN not yet assigned
|
4201
|
|
4201.html
|
4201.pdf
|
Altropane
|
|
[180468-34-2]
|
4210
|
|
4210.html
|
4210.pdf
|
Altropane Hydrochloride
|
|
CAS-RN not yet assigned
|
4211
|
|
4211.html
|
4211.pdf
|
MASB
|
|
[296774-10-2]
|
4300
|
|
4300.html
|
4300.pdf
|
MASB (GMP)
|
|
[296774-10-2]
|
4301
|
|
4301.html
|
4301.pdf
|
DASB
|
|
[627490-01-1]
|
4310
|
|
4310.html
|
4310.pdf
|
DASB (GMP)
|
|
[627490-01-1]
|
4311
|
|
4311.html
|
4311.pdf
|
AFM-Precursor
|
|
CAS-RN not yet assigned
|
4320
|
|
4320.html
|
4320.pdf
|
AFM-Standard
|
|
CAS-RN not yet assigned
|
4330
|
|
4330.html
|
4330.pdf
|
(+)-McN 5652 Thiobutyrate
|
|
CAS-RN not yet assigned
|
4360
|
|
4360.html
|
4360.pdf
|
(+)-McN 5652
|
|
[259145-56-7]
|
4370
|
|
4370.html
|
4370.pdf
|
(-)-McN 5652
|
|
[262352-33-0]
|
4380
|
|
4380.html
|
4380.pdf
|
(+)-Fluoromethyl-McN 5652
|
|
CAS-RN not yet assigned
|
4381
|
|
4381.html
|
4381.pdf
|
CPTMA
|
|
[124915-01-1]
|
4385
|
|
4385.html
|
4385.pdf
|
TBAB
|
|
[660845-84-1]
|
4389
|
|
4389.html
|
4389.pdf
|
PMBAB
|
|
[223699-69-2]
|
4390
|
|
4390.html
|
4390.pdf
|
FB-Precursor
|
|
[124915-06-6]
|
4391
|
|
4391.html
|
4391.pdf
|
SFB
|
|
[66134-67-6]
|
4392
|
|
4392.html
|
4392.pdf
|
Precursor for [18F]FPyBrA and [18F]FPyME
|
|
[640749-64-0]
|
4393
|
|
4393.html
|
4393.pdf
|
Precursor for [18F]FPyKYNE
|
|
[1161009-68-2]
|
4396
|
|
4396.html
|
4396.pdf
|
FPyKYNE
|
|
[1161009-63-7]
|
4397
|
|
4397.html
|
4397.pdf
|
(2S,3S)-N-Boc-norethylreboxetine
|
|
[754988-84-6]
|
4400
|
|
4400.html
|
4400.pdf
|
(2S,3S)-Methylreboxetine
|
|
[105018-14-2]
|
4406
|
|
4406.html
|
4406.pdf
|
Norbinaltorphimine dihydrochloride
|
|
[113158-34-2]
|
4500
|
|
4500.html
|
4500.pdf
|
(-)-TEBV
|
|
[153215-71-5]
|
4600
|
|
4600.html
|
4600.pdf
|
(-)-FEBV
|
|
[153215-70-4]
|
4610
|
|
4610.html
|
4610.pdf
|
(±)-9-O-Desmethyl-alpha-dihydrotetrabenazine
|
|
[5220-98-4]
|
4700
|
|
4700.html
|
4700.pdf
|
(+)-9-O-Desmethyl-alpha-dihydrotetrabenazine
|
|
CAS-RN not yet assigned
|
4710
|
|
4710.html
|
4710.pdf
|
(-)-9-O-Desmethyl-alpha-dihydrotetrabenazine
|
|
CAS-RN not yet assigned
|
4720
|
|
4720.html
|
4720.pdf
|
(±)-alpha-Dihydrotetrabenazine
|
|
[3466-75-9]
|
4730
|
|
4730.html
|
4730.pdf
|
Aminothiadiazine
|
|
[319002-53-4]
|
4900
|
|
4900.html
|
4900.pdf
|
Chlorothiadiazine
|
|
[194086-61-8]
|
4910
|
|
4910.html
|
4910.pdf
|
DMTEAN
Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union.
|
|
[259739-02-1]
|
5000
|
|
5000.html
|
5000.pdf
|
DFEAN
Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union.
|
|
CAS-RN not yet assigned
|
5010
|
|
5010.html
|
5010.pdf
|
DMEAN
Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union.
|
|
[259739-01-0]
|
5020
|
|
5020.html
|
5020.pdf
|
DMFEAN
Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union.
|
|
[590365-47-2]
|
5030
|
|
5030.html
|
5030.pdf
|
6-OH-BTA-0
|
|
[178804-18-7]
|
5100
|
|
5100.html
|
5100.pdf
|
6-OH-BTA-0 (GMP)
|
|
[178804-18-7]
|
5101
|
|
5101.html
|
5101.pdf
|
6-MOMO-BTA-0
|
|
[566170-03-4]
|
5110
|
|
5110.html
|
5110.pdf
|
6-OH-BTA-1 Hydrochloride
|
|
CAS-RN not yet assigned
|
5120
|
|
5120.html
|
5120.pdf
|
6-MeO-BTA-0
|
|
[43036-17-5]
|
5130
|
|
5130.html
|
5130.pdf
|
6-OH-BTA-1 (free base)
|
|
[566169-93-5]
|
5140
|
|
5140.html
|
5140.pdf
|
Coumarin 16
|
|
[58851-99-3]
|
5159
|
|
5159.html
|
5159.pdf
|
3-(2-Benzoxazoly)-7-hydroxycoumarin
|
|
[64887-40-7]
|
5161
|
|
5161.html
|
5161.pdf
|
Desmethyl-PD 153035
|
|
[295330-61-9]
|
5200
|
|
5200.html
|
5200.pdf
|
PD 153035
|
|
[153436-54-5]
|
5210
|
|
5210.html
|
5210.pdf
|
Norverapamil
|
|
[67018-85-3]
|
5600
|
|
5600.html
|
5600.pdf
|
(+)-Norverapamil
|
|
[123932-43-4]
|
5610
|
|
5610.html
|
5610.pdf
|
(-)-Norverapamil
|
|
[123931-31-7]
|
5620
|
|
5620.html
|
5620.pdf
|
(+)-Verapamil Hydrochloride
|
|
[38176-02-2]
|
5630
|
|
5630.html
|
5630.pdf
|
Rolipram
|
|
[61413-54-5]
|
6000
|
|
6000.html
|
6000.pdf
|
Desmethyl-Rolipram
|
|
[150519-28-1]
|
6030
|
|
6030.html
|
6030.pdf
|
(S)-(+)-Desmethyl-Rolipram
|
|
[347148-60-1]
|
6040
|
|
6040.html
|
6040.pdf
|
(R)-(-)-Desmethyl-Rolipram
|
|
[347148-59-8]
|
6050
|
|
6050.html
|
6050.pdf
|
Dimethylaminoethanol
|
|
[108-01-0]
|
6100
|
|
6100.html
|
6100.pdf
|
Fluoroethylcholine bromide
|
|
[733050-47-0]
|
6110
|
|
6110.html
|
6110.pdf
|
Fluoroethylcholine tosylate
|
|
[479407-07-3]
|
6120
|
|
6120.html
|
6120.pdf
|
Fluoromethylcholine chloride
|
|
[459424-38-5]
|
6130
|
|
6130.html
|
6130.pdf
|
Fluoromethylcholine bromide
|
|
CAS-RN not yet assigned
|
6140
|
|
6140.html
|
6140.pdf
|
Choline chloride
|
|
[67-48-1]
|
6150
|
|
6150.html
|
6150.pdf
|
Fluoroethylcholine chloride
|
|
[479407-08-4]
|
6160
|
|
6160.html
|
6160.pdf
|
Choline iodide
|
|
[17773-10-3]
|
6170
|
|
6170.html
|
6170.pdf
|
Dibromoethane
|
|
[106-93-4]
|
6175
|
|
6175.html
|
6175.pdf
|
Dibromomethane
|
|
[74-95-3]
|
6176
|
|
6176.html
|
6176.pdf
|
1,2-Bis(nosyloxy)ethane
|
|
[25297-82-9]
|
6179
|
|
6179.html
|
6179.pdf
|
1,2-Bis(tosyloxy)ethane
|
|
[6315-52-2]
|
6180
|
|
6180.html
|
6180.pdf
|
2-Bromoethyl nosylate
|
|
[52331-22-3]
|
6181
|
|
6181.html
|
6181.pdf
|
2-Bromoethyl triflate
|
|
[103935-47-3]
|
6182
|
|
6182.html
|
6182.pdf
|
2-Bromoethyl tosylate
|
|
[19263-21-9]
|
6183
|
|
6183.html
|
6183.pdf
|
2-Fluoroethyl tosylate
|
|
[383-50-6]
|
6184
|
|
6184.html
|
6184.pdf
|
Bis(tosyl)-1,4-butanediol
|
|
[4724-56-5]
|
6185
|
|
6185.html
|
6185.pdf
|
1,4-Bis(tosyloxy)but-2-yne
|
|
[6337-59-3]
|
6186
|
|
6186.html
|
6186.pdf
|
3-Fluoropropyltosylate
|
|
[312-68-5]
|
6190
|
|
6190.html
|
6190.pdf
|
1,3-Propane-di-tosylate
|
|
[5469-66-9]
|
6191
|
|
6191.html
|
6191.pdf
|
Ethyl (p-tosyloxy)acetate
|
|
[39794-75-7]
|
6200
|
|
6200.html
|
6200.pdf
|
Potassium fluoroacetate
|
|
[23745-86-0]
|
6210
|
|
6210.html
|
6210.pdf
|
Sodium fluoroacetate
|
|
[62-74-8]
|
6211
|
|
6211.html
|
6211.pdf
|
1-Tosyloxy-3-butyne
|
|
[23418-85-1]
|
6301
|
|
6301.html
|
6301.pdf
|
1-Tosyloxy-4-pentyne
|
|
[77758-50-0]
|
6302
|
|
6302.html
|
6302.pdf
|
1-Tosyloxy-5-hexyne
|
|
[76911-01-8]
|
6303
|
|
6303.html
|
6303.pdf
|
Tosyl-propargyl-diethylene glycol
|
|
[1119249-30-7]
|
6305
|
|
6305.html
|
6305.pdf
|
Tosyl-propargyl-triethylene glycol
|
|
[888009-94-7]
|
6307
|
|
6307.html
|
6307.pdf
|
Dimethyl-8-acetyl-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate
|
|
[79465-83-1]
|
6500
|
|
6500.html
|
6500.pdf
|
alpha-Methyl-L-tryptophan
|
|
[16709-25-4]
|
6510
|
|
6510.html
|
6510.pdf
|
Dimethyl-8-phenylsulfonyl-5-phenylsulfonyloxy-hexahydropyrrolo[2,3]indol-1,2-dicarboxylate
|
|
[150804-39-0]
|
6520
|
|
6520.html
|
6520.pdf
|
MIBG
|
|
[87862-25-7]
|
7000
|
|
7000.html
|
7000.pdf
|
MIBG (GMP)
|
|
[87862-25-7]
|
7001
|
|
7001.html
|
7001.pdf
|
MTMSBG
|
|
CAS-RN not yet assigned
|
7010
|
|
7010.html
|
7010.pdf
|
CNS 1261
|
|
[341032-67-5]
|
7020
|
|
7020.html
|
7020.pdf
|
TBS-CNS 1261
|
|
[765890-24-2]
|
7030
|
|
7030.html
|
7030.pdf
|
Mebrofenin
|
|
[78266-06-5]
|
7050
|
|
7050.html
|
7050.pdf
|
Disofenin
|
|
[65717-97-7]
|
7060
|
|
7060.html
|
7060.pdf
|
Succinimidyl-N-Boc-Hynic
|
|
[133081-26-2]
|
7080
|
|
7080.html
|
7080.pdf
|
Succinimidyl-Hynic hydrochloride
|
|
[133081-27-3]
|
7090
|
|
7090.html
|
7090.pdf
|
S-Benzoyl-MAG-3
|
|
[103725-47-9]
|
7100
|
|
7100.html
|
7100.pdf
|
MAG 3
|
|
[66516-09-4]
|
7110
|
|
7110.html
|
7110.pdf
|
(Benzoylmercapto)acetic acid
|
|
[6398-74-9]
|
7111
|
|
7111.html
|
7111.pdf
|
BMEDA
|
|
[93798-62-0]
|
7150
|
|
7150.html
|
7150.pdf
|
MDP
|
|
[1984-15-2]
|
7160
|
|
7160.html
|
7160.pdf
|
HMDP
|
|
[14255-61-9]
|
7161
|
|
7161.html
|
7161.pdf
|
MIBI
|
|
[109434-22-2]
|
7200
|
|
7200.html
|
7200.pdf
|
Copper tetraMIBI tetrafluoroborate [Cu(MIBI)4]BF4
|
|
[103694-84-4]
|
7210
|
|
7210.html
|
7210.pdf
|
Copper tetraMIBI tetrafluoroborate (GMP)
|
|
[103694-84-4]
|
7211
|
|
7211.html
|
7211.pdf
|
Zinc-TBI
|
|
[104676-71-3]
|
7220
|
|
7220.html
|
7220.pdf
|
EC
|
|
[14344-48-0]
|
7250
|
|
7250.html
|
7250.pdf
|
ECD
|
|
[14344-58-2]
|
7260
|
|
7260.html
|
7260.pdf
|
DOTA
|
|
[60239-18-1]
|
7300
|
|
7300.html
|
7300.pdf
|
DOTAEt
|
|
[137076-50-7]
|
7301
|
|
7301.html
|
7301.pdf
|
Tetrofosmin
|
|
[127502-06-1]
|
7310
|
|
7310.html
|
7310.pdf
|
Disodium sulfosalicylate
|
|
[56343-01-2]
|
7312
|
|
7312.html
|
7312.pdf
|
TRODAT
|
|
[189950-11-6]
|
7400
|
|
7400.html
|
7400.pdf
|
S-(-)-BZM
|
|
[84226-04-0]
|
7500
|
|
7500.html
|
7500.pdf
|
S-(-)-IBZM
|
|
[84226-06-2]
|
7510
|
|
7510.html
|
7510.pdf
|
16-Iodohexadecanoic acid
|
|
[2536-36-9]
|
7600
|
|
7600.html
|
7600.pdf
|
Ubiquicidin (29-41) acetate
|
|
[216867-99-1] (net peptide)
|
9600
|
|
9600.html
|
9600.pdf
|
DOTA-NOC acetate
|
|
[619300-53-7] (net peptide)
|
9712
|
|
9712.html
|
9712.pdf
|
AMBA acetate
|
|
[721937-56-0] (net peptide)
|
9714
|
|
9714.html
|
9714.pdf
|
DOTA-[Pro1,Tyr4]bombesin (1-14)
|
|
[593287-40-2] (net peptide)
|
9715
|
|
9715.html
|
9715.pdf
|
DOTA-NOC acetate (GMP)
|
|
[619300-53-7] (net peptide)
|
9716
|
|
9716.html
|
9716.pdf
|
HYNIC-TOC trifluoroacetate
|
|
[257943-19-4] (net peptide)
|
9721
|
|
9721.html
|
9721.pdf
|
HYNIC-NOC trifluoroacetate
|
|
CAS-RN not yet assigned
|
9730
|
|
9730.html
|
9730.pdf
|
Pentreotide trifluoroacetate
|
|
[138661-02-6] (net peptide)
|
9740
|
|
9740.html
|
9740.pdf
|
Octreotide acetate
|
|
[79517-01-4] (net peptide)
|
9750
|
|
9750.html
|
9750.pdf
|
[Nal3]Octreotide acetate
|
|
[848820-27-9] (net peptide)
|
9752
|
|
9752.html
|
9752.pdf
|
TETA-Octreotide acetate
|
|
[226084-96-4] (net peptide)
|
9760
|
|
9760.html
|
9760.pdf
|
DOTA-TATE acetate
|
|
[177943-89-4]
|
9770
|
|
9770.html
|
9770.pdf
|
DOTA-TATE acetate (GMP)
|
|
[177943-89-4]
|
9772
|
|
9772.html
|
9772.pdf
|
Ga-DOTA-TATE (Referenzstandard)
|
|
[293295-75-7]
|
9773
|
|
9773.html
|
9773.pdf
|
[Tyr3]octreotate acetate
|
|
[302794-43-0] (net peptide)
|
9774
|
|
9774.html
|
9774.pdf
|
HYNIC-TATE trifluoroacetate
|
|
[930123-09-4] (net peptide)
|
9781
|
|
9781.html
|
9781.pdf
|
Galacto-RGD
|
|
[922175-70-0] (net peptide)
|
9790
|
|
9790.html
|
9790.pdf
|
Fluoropropionyl-Galacto-RGD
|
|
CAS-RN not yet assigned
|
9800
|
|
9800.html
|
9800.pdf
|
NODAGA-RGD trifluoroacetate
|
|
CAS-RN not yet assigned
|
9805
|
|
9805.html
|
9805.pdf
|
[Tyr3]octreotide acetate
|
|
[103667-46-5] (net peptide)
|
9810
|
|
9810.html
|
9810.pdf
|
Lanreotide trifluoroacetate
|
|
[108736-35-2] (net peptide)
|
9820
|
|
9820.html
|
9820.pdf
|
DOTA-Lanreotide trifluoroacetate
|
|
[213187-44-1] (net peptide)
|
9830
|
|
9830.html
|
9830.pdf
|
DOTA-Lanreotide acetate
|
|
[213187-44-1] (net peptide)
|
9831
|
|
9831.html
|
9831.pdf
|
HYNIC-Lanreotide trifluoroacetate
|
|
CAS-RN not yet assigned
|
9836
|
|
9836.html
|
9836.pdf
|
4-Formyl-N,N,N-Trimethylanilinium triflate
|
|
[124915-02-2]
|
9850
|
|
9850.html
|
9850.pdf
|
[Tyr3,Lys5(Boc)]octreotide acetate
|
|
[147790-89-4] (net peptide)
|
9900
|
|
9900.html
|
9900.pdf
|
[Lys5(Boc)]octreotate acetate
|
|
[133304-78-6] (net peptide)
|
9901
|
|
9901.html
|
9901.pdf
|
[Lys5(Boc)]lanreotide acetate
|
|
[182482-12-8] (net peptide)
|
9902
|
|
9902.html
|
9902.pdf
|
[Nal3,Lys5(Boc)]octreotide acetate
|
|
CAS-RN not yet assigned
|
9903
|
|
9903.html
|
9903.pdf
|
[Nal3,Lys5(Boc)]octreotide acetate
|
|
CAS-RN not yet assigned
|
9903
|
|
9903.html
|
9903.pdf
|